NASDAQ:INNV InnovAge (INNV) Stock Price, News & Analysis $8.64 -0.28 (-3.09%) As of 01:59 PM Eastern This is a fair market value price provided by Massive. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsInsider TradesNews and TrendsOptions ChainOwnershipSEC FilingsShort Interest About InnovAge Stock (NASDAQ:INNV) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get InnovAge alerts:Sign Up Key Stats Today's Range$8.24▼$9.3050-Day Range$8.80▼$10.9252-Week Range$4.70▼$12.64Volume267,472 shsAverage Volume386,243 shsMarket Capitalization$1.18 billionP/E Ratio143.50Dividend YieldN/APrice Target$10.50Consensus RatingModerate Buy Company Overview InnovAge, Inc. provides integrated healthcare and social services to older adults through the Program of All-Inclusive Care for the Elderly (PACE). The program serves people who qualify for nursing-home-level care but can continue living in their communities with coordinated support. InnovAge’s services include primary and specialty care coordination, nursing, rehabilitation, social services, prescription medications, transportation, in-home assistance and adult day health services. Care is coordinated by interdisciplinary teams and delivered through a combination of community-based centers and support at home. The company operates PACE programs in Colorado, California, New Mexico, Pennsylvania and Virginia. Its model is designed to bring medical and supportive services together around each participant’s needs, helping eligible older adults remain in their homes and communities.AI Generated. May Contain Errors. Read More InnovAge Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks75th Percentile Overall ScoreINNV MarketRank™: 3.749147920925 of 5 starsInnovAge scored higher than 75% of companies evaluated by MarketBeat, and ranked 457th out of 1,704 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion3.7 / 5Analyst RatingModerate Buy Consensus RatingInnovAge has received a consensus rating of Moderate Buy. The company's average rating score is 2.50, and is based on 1 strong buy rating, 1 buy rating, 1 hold rating, and 1 sell rating.Upside PotentialInnovAge has a consensus price target of $10.50, representing about 22.9% upside from its current price of $8.55.Amount of Analyst CoverageInnovAge has only been the subject of 3 research reports in the past 90 days.Read more about InnovAge's stock forecast and price target. Earnings and Valuation1.3 / 5Proj. Earnings Growth11.36% Earnings GrowthEarnings for InnovAge are expected to grow by 11.36% in the coming year, from $0.44 to $0.49 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of InnovAge is 143.00, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 25.80.Price to Earnings Ratio vs. SectorThe P/E ratio of InnovAge is 143.00, which means that it is trading at a more expensive P/E ratio than the Healthcare sector average P/E ratio of about 33.05.Price to Book Value per Share RatioInnovAge has a P/B Ratio of 4.52. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.Read more about InnovAge's valuation and earnings. Short Interest5.0 / 5Short Interest LevelHealthy Percentage of Shares Shorted0.66% of the float of InnovAge has been sold short.Short Interest Ratio / Days to CoverInnovAge has a short interest ratio ("days to cover") of 1.44, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in InnovAge has recently decreased by 22.08%, indicating that investor sentiment is improving significantly. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldInnovAge does not currently pay a dividend.Dividend GrowthInnovAge does not have a long track record of dividend growth. News and Social Media2.9 / 5News Sentiment0.62 News SentimentInnovAge has a news sentiment score of 0.62. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.37 average news sentiment score of Healthcare companies.News Coverage This WeekMarketBeat has tracked 10 news articles for InnovAge this week, compared to 3 articles on an average week.MarketBeat FollowsOnly 1 people have added InnovAge to their MarketBeat watchlist in the last 30 days. This is a decrease of -50% compared to the previous 30 days. Company Ownership0.9 / 5Insider TradingSelling Shares Insider Buying vs. Insider SellingIn the past three months, InnovAge insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $120,489,535.00 in company stock.Percentage Held by Insiders1.10% of the stock of InnovAge is held by insiders.Percentage Held by Institutions12.26% of the stock of InnovAge is held by institutions.Read more about InnovAge's insider trading history. Receive INNV Stock News and Ratings via Email Sign-up to receive the latest news and ratings for InnovAge and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. INNV Stock News HeadlinesInnovAge Resolves Federal, State Claims Over Historical PracticesNovember 18 at 6:36 PM | marketscreener.comMInnovAge Holding Corp. Announces $37 Million Settlement With U.S. Department of Justice and Participating StatesNovember 18 at 4:31 PM | quiverquant.comQYou missed yesterday's deadline…In June 2025, a drilling crew near the Grand Canyon uncovered an energy source producing nearly eight times the output of Saudi Arabia's largest oil well, enough potential energy to power civilization for two million years. While the One Big Beautiful Bill Act stripped tax credits from solar, wind, and EVs on July 4th, this discovery was reclassified alongside oil and nuclear and secured eight years of credits. Google signed a 15-year contract, and Bill Gates committed 100 million dollars.November 19 at 1:00 AM | Behind the Markets (Ad)InnovAge Holding Corp. Resolves Civil Matter with U.S. Department of Justice & Participating StatesNovember 18 at 4:05 PM | globenewswire.comInnovAge Holding to Pay $36 Million to Resolve Allegations of False Claims Act, State Law Violations -- UpdateNovember 17 at 2:26 PM | marketscreener.comMInnovAge Holding to Pay $36 Million to Resolve Allegations of False Claims Act, State Law ViolationsNovember 17 at 12:22 PM | marketscreener.comMInnovAge (NASDAQ:INNV) Insider Nicole Damato Sells 3,402 Shares of Company StockOctober 27, 2026 | insidertrades.comInnovAge (NASDAQ:INNV) Major Shareholder Sells $13,875,000.00 in StockOctober 24, 2026 | insidertrades.comSee More Headlines INNV Stock Analysis - Frequently Asked Questions How have INNV shares performed this year? InnovAge's stock was trading at $5.19 at the beginning of the year. Since then, INNV shares have increased by 64.6% and is now trading at $8.5450. How were InnovAge's earnings last quarter? InnovAge Holding Corp. (NASDAQ:INNV) posted its earnings results on Tuesday, November, 3rd. The company reported $0.14 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.09 by $0.05. The company had revenue of $264.76 million for the quarter, compared to the consensus estimate of $257.23 million. InnovAge had a trailing twelve-month return on equity of 3.63% and a net margin of 0.88%. Read the conference call transcript. When did InnovAge IPO? InnovAge (INNV) raised $342 million in an IPO on Thursday, March 4th 2021. The company issued 16,666,667 shares at $20.00-$21.00 per share. J.P. Morgan, Barclays, Goldman Sachs and Citigroup served as the underwriters for the IPO and Baird, William Blair, Piper Sandler, Capital One Securities, Loop Capital Markets, Siebert Williams Shank and Roberts & Ryan were co-managers. Who are InnovAge's major shareholders? InnovAge's top institutional investors include Goldman Sachs Group Inc. (0.49%), State Street Corp (0.34%), Marshall Wace LLP (0.30%) and Ritholtz Wealth Management (0.18%). Insiders that own company stock include Carson Anderson & Stow Welsh, Aggregator Lp Ignite, Nicole Damato, Michael Anthony Scarbrough, Richard C Zoretic and Richard C Zoretic. View institutional ownership trends. How do I buy shares of InnovAge? Shares of INNV stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of InnovAge own? Based on aggregate information from My MarketBeat watchlists, some other companies that InnovAge investors own include Walt Disney (DIS), NVIDIA (NVDA), Visa (V), Energy Transfer (ET), American International Group (AIG), Blackstone (BX) and Enterprise Products Partners (EPD). Company Calendar Last Earnings11/03/2026Today11/19/2026Next Earnings (Estimated)2/02/2027Fiscal Year End6/30/2027Get Stock Alerts Health Indicator TradeSmith's Health IndicatorA long-term volatility-based measure designed for securities held 12 months or longer.Green: Strong and healthy uptrend with normal pullbacks.Yellow: Significant pullback but still within expected volatility.Red: Dropped beyond expected volatility; considered unhealthy. Green Zone (5m+) 1-Year History Nov 25 Feb 26 May 26 Aug 26 Nov 26 INNV's financial health is in the Green zone, according to TradeSmith. INNV has been in this zone for over 5 months. Industry, Sector and Symbol Stock ExchangeNASDAQ SectorHealthcare Industry Healthcare Providers & Services Sub-IndustryHealthcare Services Current SymbolNASDAQ:INNV Previous SymbolOTCMKTS:INNV CIK1834376 Webwww.innovage.com Phone844-803-8745FaxN/AEmployees2,500Year Founded1990Price Target and Rating Average Price Target for InnovAge$10.50 High Price Target$14.00 Low Price Target$7.00 Potential Upside/Downside+21.0%Consensus RatingModerate Buy Rating Score (0-4)2.50 Research Coverage4 Analysts Profitability EPS (Trailing Twelve Months)$0.06 Trailing P/E Ratio144.58 Forward P/E Ratio17.71 P/E GrowthN/ANet Income-$2.54 million Net Margins0.88% Pretax Margin1.22% Return on Equity3.63% Return on Assets1.64% Debt Debt-to-Equity Ratio0.20 Current Ratio1.16 Quick Ratio1.16 Sales & Book Value Annual Sales$1.02 billion Price / Sales1.16 Cash Flow$0.13 per share Price / Cash Flow65.99 Book Value$1.89 per share Price / Book4.59Miscellaneous Outstanding Shares136,457,000Free Float134,956,000Market Cap$1.18 billion OptionableOptionable Beta0.16 Social Links 7 Stocks That Could Lead the Next Market BoomTesla, Nvidia, and Google helped shape the last era of market growth, but the next wave could come from a new group of companies. Inside this report, you’ll find 7 stocks that could play a major role in the next tech-driven market boom.Get This Free Report This page (NASDAQ:INNV) was last updated on 11/19/2026 by MarketBeat.com Staff. From Our PartnersYour $7 scanner is waitingThe Instant Scanner is $7 in Bill Poulos's Black Friday sale. Every night it delivers a list showing which sto...Profits Run | SponsoredPentagon magnet restrictions take effect January 1, 2027A NASDAQ-listed company has signed a term sheet outlining a potential 75-year agreement with the U.S. Army. It...OilPrice | SponsoredTop Trader Reveals Stunning Black Friday DealOthers paid $500 for the Snapback Indicator. This Black Friday, it's available for just $7. Base Camp Tradi...Base Camp Trading | SponsoredToday's free pick (on me)Elon Musk doesn't own the chip inside every Tesla, Starlink dish, and AI satellite - he licenses it from one l...Behind the Markets | SponsoredChase, Wells Fargo and Capital One all showed errors on Nov. 16On November 16, customers of Chase, Bank of America, Wells Fargo, Capital One and Zelle reported errors when t...Cedar Gold Group | SponsoredYour father's savings lost half their value after 1971.On August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...Reagan Gold Group | SponsoredThe Democrats can’t stop thisPorter Stansberry believes President Trump has begun a full dollar reset through executive order 14241, bypass...Porter & Company | SponsoredA Bill Would Reprice America's Gold at Market ValueThe US government still values its gold at $42 an ounce, a price Congress set in 1973. Gold trades above $4,00...Concord Gold Capital | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding InnovAge Holding Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share InnovAge With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.